Nov 17, 2022

How patients can improve the way new cancer therapies are assessed

Mar 24, 2021

OICR, Intensity Therapeutics and The Ottawa Hospital to conduct Window of Opportunity clinical trial in early-stage breast cancer

Jul 08, 2020

Protecting cancer patients from COVID-19: world-first clinical trial tests a novel immune-boosting strategy

Nov 13, 2019

Winning presentation points to more personalized medicine at OMPRN Pathology Matters meeting

Sep 20, 2019

Harnessing the time before a patient’s surgery to accelerate cancer research

Jul 03, 2019

Five fellows, four labs, three years, two countries, and a generous donation

May 17, 2018

Combination of erectile dysfunction drugs and flu vaccine may help kill remaining cancer after surgery

Jan 19, 2018

Scientists create method to sensitize triple-negative breast cancer to common immunotherapy

Jan 04, 2018

Study shows virus-boosted immunotherapy can be effective against aggressive breast cancer

Oct 11, 2017

Ontario start-up makes major deal to develop cancer-fighting viruses

Jul 11, 2017

How OICR is helping to boost the body’s ability to fight cancer

May 25, 2017

OICR launches five all-star teams of Ontario scientists to tackle some of the deadliest forms of cancer

May 25, 2017

OICR launches five large-scale Ontario research initiatives to combat some of the most deadly cancers

May 03, 2017

Study bringing more precision medicine to Ontario’s cancer patients

Apr 26, 2017

Clinical trial opens for promising combination therapy

Jan 05, 2016

OICR funds world-first clinical trial using cancer-fighting viruses

Nov 09, 2015

FACIT start-up company Turnstone Biologics secures $11.3 million in financing, boosts leadership

Feb 25, 2015

OICR extends collaboration with Janssen Inc. to develop clinical trials for prostate cancer